Natural History, Disease Progression, and Long-Term Neurologic Sequelae of Ebola Virus Disease (EVD) Survivors in PREVAIL III
Clinical trial NCT05494801 · COMPLETED
Trial details
- NCT number
- NCT05494801
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-08-25
- Primary completion
- 2023-03-25
- Enrollment
- 203
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.